< Return to trials

Peripheral Artery Disease (PAD)

Overview

Lillestol Research has trial experience in the peripheral artery disease (PAD) indication/diagnosis. Our research patient database also holds a multitude of patients with this diagnosis that would be interested in clinical trial participation.


Spotlight Trial(s)

This was a long-term comparator trial of 2 medications and their effect on the event rate of cardiovascular (CV) death, myocardial infarction (MI), and ischaemic stroke in patients with established PAD. Lillestol Research was able to screen 19 patients and randomize 7 patients in a 13-month enrollment period. This trial is another highlight to our excellent patient retention rate with all 7 subjects continuing on in the trial after nearly 3 years of participation.